Ovarian tumors with functioning manifestations

Endocrine Pathology
Fattaneh A Tavassoli

Abstract

Various categories of ovarian tumors, particularly those of gonadal stromal origin, are capable of producing a variety of hormones that occasionally induce interesting clinical manifestations. The endocrine manifestations associated with gonadal stromal tumors are often due to hormone production by the tumor cells. Sometimes the tumor cells produce only one hormone, while more frequently the hormonal manifestations result from a summation of various hormones including transformation of a variety of prehormones produced by different components of the tumor including its supportive or reactive stroma. The mechanisms involved in the production and transformation of various hormones and prehormones are complex and not thoroughly established at this time. This review will focus on gonadal stromal tumors and discuss evidence available for linkage of the clinical manifestations to hormones produced by the various neoplasms.

References

Jun 15, 1978·American Journal of Obstetrics and Gynecology·L M BonaventuraR E Cleary
Jun 1, 1979·Cancer·R J KurmanC R Taylor
Sep 1, 1979·Histopathology·D C Gee, P Russell
Jun 1, 1975·Obstetrics and Gynecology·I DamajanovN Longhino
Jan 1, 1988·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·R M Lam, P Geittmann
Jan 1, 1986·Acta Obstetricia Et Gynecologica Scandinavica·S JeppssonS Kullander
Feb 1, 1986·Australian and New Zealand Journal of Medicine·B JacksonG Wagner
Jan 1, 1987·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·R H Young, R E Scully
Oct 1, 1986·Gynecologic Oncology·C G MählckO Kjellgren
Jan 1, 1986·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·J L Rutgers, R E Scully
Aug 1, 1985·The American Journal of Surgical Pathology·R H Young, R E Scully
Sep 1, 1985·Gynecologic Oncology·S L TracyR J Kurman
Nov 1, 1967·Cancer·H B Taylor, H J Norris
Feb 1, 1968·The Journal of Clinical Endocrinology and Metabolism·T B ConnorL G Martin
Dec 1, 1968·American Journal of Obstetrics and Gynecology·A Pfleiderer, G Teufel
Mar 1, 1970·The Journal of Clinical Endocrinology and Metabolism·M B LipsettC W Bardin
May 15, 1970·American Journal of Obstetrics and Gynecology·V B MaheshC A Deleo
Jun 1, 1973·American Journal of Obstetrics and Gynecology·E V YounglaiF L Johnson
Jul 15, 1974·American Journal of Obstetrics and Gynecology·C S Targett
Jun 1, 1973·American Journal of Obstetrics and Gynecology·T ShinadaS Matsumoto
Feb 1, 1968·Cancer·H J Norris, H B Taylor
Apr 1, 1971·Cancer·S H Dikman, C Toker
Oct 1, 1966·American Journal of Obstetrics and Gynecology·I TakiM Mori
Jan 1, 1982·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·J ZhangR E Scully
Oct 1, 1983·The Journal of Clinical Endocrinology and Metabolism·N J MariebP E Schwartz
Jan 1, 1983·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·C HsuL Mak
Jan 1, 1984·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·H E Stegner, B P Lisboa
Jan 1, 1983·Virchows Archiv. A, Pathological Anatomy and Histopathology·G MartinelliG Pelusi
Aug 1, 1984·The American Journal of Surgical Pathology·R H YoungR E Scully
Mar 1, 1984·Pathology, Research and Practice·Z Detre, E Földes
Jun 1, 1984·The American Journal of Surgical Pathology·C Zaloudek, H J Norris
Apr 1, 1983·The American Journal of Surgical Pathology·R H YoungR E Scully

❮ Previous
Next ❯

Citations

Mar 21, 1998·Pathology International·Y KuriharaY Tsutsumi
Nov 24, 2012·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Huiting XiaoLingying Wu
Nov 1, 1996·Biological Reviews of the Cambridge Philosophical Society·W J Murdoch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.